Literature DB >> 24992996

Hyperglycemia 3 days after esophageal cancer surgery is associated with an increased risk of postoperative infection.

Naoko Ito1, Takeshi Iwaya, Kenichiro Ikeda, Yusuke Kimura, Yuji Akiyama, Masafumi Konosu, Kaoru Ishida, Hisataka Fujiwara, Koki Otsuka, Hiroyuki Nitta, Masahiro Kashiwaba, Keisuke Koeda, Satoshi Nishizuka, Masaru Mizuno, Akira Sasaki, Go Wakabayashi.   

Abstract

PURPOSE: Postoperative hyperglycemia is associated with infectious complications after various types of surgery. Our objective was to determine whether postoperative blood glucose levels up to 1 week after highly invasive esophageal cancer surgery are associated with the incidence of postoperative infections (POIs).
METHODS: We conducted a retrospective chart review of 109 consecutive thoracic esophageal squamous cell cancer patients who underwent invasive esophagectomy with thoracotomy and laparotomy. The incidence of postoperative POIs and risk factors for POIs, including postoperative blood glucose levels, were evaluated.
RESULTS: Of the 109 patients, 37 (34.0 %) developed POIs. Clinically, 73.0 % of the POIs became evident on or after postoperative day 4 (median, 5.25 days; interquartile range, 3.00-9.25 days). On and after postoperative day 3, chronological changes in blood glucose levels were significantly different between two groups of patients with or without POIs, as indicated by repeated measures ANOVA (P = 0.006). Multivariate logistic regression analysis results showed that an increased blood glucose concentration on postoperative day 3 was a significant risk factor for POIs.
CONCLUSIONS: Our findings suggested that postoperative hyperglycemia on postoperative day 3 was a predictive factor of POIs after highly invasive esophageal cancer surgery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24992996     DOI: 10.1007/s11605-014-2587-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  28 in total

1.  Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer.

Authors:  Nobuhiro Sato; Keisuke Koeda; Kenichiro Ikeda; Yusuke Kimura; Kiichi Aoki; Takeshi Iwaya; Yuji Akiyama; Kaoru Ishida; Kazuyoshi Saito; Shigeatsu Endo
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

Review 2.  Clinical practice. Glycemic control in the ICU.

Authors:  Brian P Kavanagh; Karen C McCowen
Journal:  N Engl J Med       Date:  2010-12-23       Impact factor: 91.245

3.  Surgical site infection in elective operations for colorectal cancer after the application of preventive measures.

Authors:  Xavier Serra-Aracil; María Isabel García-Domingo; David Parés; Eloi Espin-Basany; Sebastiano Biondo; Xavier Guirao; Carola Orrego; Antonio Sitges-Serra
Journal:  Arch Surg       Date:  2011-05

4.  Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients.

Authors:  Gunjan Y Gandhi; Gregory A Nuttall; Martin D Abel; Charles J Mullany; Hartzell V Schaff; Brent A Williams; Lisa M Schrader; Robert A Rizza; M Molly McMahon
Journal:  Mayo Clin Proc       Date:  2005-07       Impact factor: 7.616

5.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

Authors:  J F Bosset; M Gignoux; J P Triboulet; E Tiret; G Mantion; D Elias; P Lozach; J C Ollier; J J Pavy; M Mercier; T Sahmoud
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

Review 6.  Role of salvage esophagectomy after definitive chemoradiotherapy.

Authors:  Yuji Tachimori
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-02-12

7.  Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation.

Authors:  Chulsoo Park; Chehao Hsu; Gundappa Neelakanta; Hamid Nourmand; Michelle Braunfeld; Christopher Wray; Randolph H Steadman; Ke-Qin Hu; Ronald T Cheng; Victor W Xia
Journal:  Transplantation       Date:  2009-04-15       Impact factor: 4.939

8.  Physiology, not chronology, dictates outcomes after esophagectomy for esophageal cancer: outcomes in patients 80 years and older.

Authors:  Sheraz R Markar; Donald E Low
Journal:  Ann Surg Oncol       Date:  2012-11-02       Impact factor: 5.344

9.  Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta-analysis.

Authors:  Kamal Nagpal; Kamran Ahmed; Amit Vats; Danny Yakoub; David James; Hutan Ashrafian; Ara Darzi; Krishna Moorthy; Thanos Athanasiou
Journal:  Surg Endosc       Date:  2010-01-28       Impact factor: 4.584

10.  Early postoperative hyperglycaemia is not a risk factor for infectious complications and prolonged in-hospital stay in patients undergoing oesophagectomy: a retrospective analysis of a prospective trial.

Authors:  Titia M Vriesendorp; J Hans DeVries; Jan B F Hulscher; Frits Holleman; Jan J van Lanschot; Joost B L Hoekstra
Journal:  Crit Care       Date:  2004-10-18       Impact factor: 9.097

View more
  11 in total

Review 1.  Measurement of Hyperglycemia and Impact on Health Outcomes in People With Cancer: Challenges and Opportunities.

Authors:  Susan Storey; Diane Von Ah; Marilyn J Hammer
Journal:  Oncol Nurs Forum       Date:  2017-07-01       Impact factor: 2.172

Review 2.  Intensive Glycemic Control in Cardiac Surgery.

Authors:  Lillian L Tsai; Hanna A Jensen; Vinod H Thourani
Journal:  Curr Diab Rep       Date:  2016-04       Impact factor: 4.810

3.  Effectiveness of intervention with a perioperative multidisciplinary support team for radical esophagectomy.

Authors:  Yuji Akiyama; Takeshi Iwaya; Fumitaka Endo; Yoshihiro Shioi; Motoi Kumagai; Takeshi Takahara; Koki Otsuka; Hiroyuki Nitta; Keisuke Koeda; Masaru Mizuno; Yusuke Kimura; Kenji Suzuki; Akira Sasaki
Journal:  Support Care Cancer       Date:  2017-06-28       Impact factor: 3.603

4.  Efficacy of thoracoscopy combined with laparoscopy and esophagectomy and analysis of the risk factors for postoperative infection.

Authors:  Junding Song; Fujuan Chu; Wenjie Zhou; Yi Huang
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

5.  The stress hyperglycemia ratio, a novel index of relative hyperglycemia, predicts short-term mortality in critically ill patients after esophagectomy.

Authors:  Zhili Xia; Ting Gu; Zhiyong Zhao; Qian Xing; Yaodong Zhang; Zhongwei Zhang; Biao Zhu
Journal:  J Gastrointest Oncol       Date:  2022-02

6.  Evaluation of the need for routine feeding jejunostomy for enteral nutrition after esophagectomy.

Authors:  Yuji Akiyama; Takeshi Iwaya; Fumitaka Endo; Haruka Nikai; Kei Sato; Shigeaki Baba; Takehiro Chiba; Toshimoto Kimura; Takeshi Takahara; Hiroyuki Nitta; Koki Otsuka; Masaru Mizuno; Yusuke Kimura; Keisuke Koeda; Akira Sasaki
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

7.  A quality assurance investigation of CLABSI events: are there exceptions to never?

Authors:  Samantha Strickler; Rohit R Gupta; John T Doucette; Roopa Kohli-Seth
Journal:  J Infect Prev       Date:  2017-07-28

8.  Association Between Preoperative Hemoglobin A1c Levels, Postoperative Hyperglycemia, and Readmissions Following Gastrointestinal Surgery.

Authors:  Caroline E Jones; Laura A Graham; Melanie S Morris; Joshua S Richman; Robert H Hollis; Tyler S Wahl; Laurel A Copeland; Edith A Burns; Kamal M F Itani; Mary T Hawn
Journal:  JAMA Surg       Date:  2017-11-01       Impact factor: 14.766

9.  Analysis of Preoperative Metabolic Risk Factors Affecting the Prognosis of Patients with Esophageal Squamous Cell Carcinoma: The Fujian Prospective Investigation of Cancer (FIESTA) Study.

Authors:  Feng Peng; Dan Hu; Xiandong Lin; Gang Chen; Binying Liang; Hejun Zhang; Xiaoqun Dong; Jinxiu Lin; Xiongwei Zheng; Wenquan Niu
Journal:  EBioMedicine       Date:  2017-01-27       Impact factor: 8.143

10.  Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?

Authors:  Katharine E Caldwell; Alexander P Conway; Chet W Hammill
Journal:  Cancer Prev Res (Phila)       Date:  2020-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.